148 related articles for article (PubMed ID: 17332319)
21. Investigating DNA adduct-targeted mutagenicity of tamoxifen: preferential formation of tamoxifen-DNA adducts in the human p53 gene in SV40 immortalized hepatocytes but not endometrial carcinoma cells.
Besaratinia A; Pfeifer GP
Biochemistry; 2005 Jun; 44(23):8418-27. PubMed ID: 15938631
[TBL] [Abstract][Full Text] [Related]
22. Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous beta-catenin.
Abdel-Rahman WM; Kalinina J; Shoman S; Eissa S; Ollikainen M; Elomaa O; Eliseenkova AV; Bützow R; Mohammadi M; Peltomäki P
Hum Mutat; 2008 Mar; 29(3):390-7. PubMed ID: 18165946
[TBL] [Abstract][Full Text] [Related]
23. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
24. Wilms' tumor gene 1 (WT1) in endometrial carcinoma.
Coosemans A; Moerman P; Verbist G; Maes W; Neven P; Vergote I; Van Gool SW; Amant F
Gynecol Oncol; 2008 Dec; 111(3):502-8. PubMed ID: 18929401
[TBL] [Abstract][Full Text] [Related]
25. Mutations of the estrogen receptor in endometrial carcinoma: evidence of an association with high tumor grade.
Assikis VJ; Bilimoria MM; Muenzner HD; Lurain JR; Jordan VC
Gynecol Oncol; 1996 Nov; 63(2):192-9. PubMed ID: 8910626
[TBL] [Abstract][Full Text] [Related]
26. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
Chen J; Li S; Yang Z; Lu G; Hu H
Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
[TBL] [Abstract][Full Text] [Related]
27. The pattern of Protease Activated Receptor 1 (PAR1) expression in endometrial carcinoma.
Granovsky-Grisaru S; Zaidoun S; Grisaru D; Yekel Y; Prus D; Beller U; Bar-Shavit R
Gynecol Oncol; 2006 Dec; 103(3):802-6. PubMed ID: 16875721
[TBL] [Abstract][Full Text] [Related]
28. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer.
Shia J; Black D; Hummer AJ; Boyd J; Soslow RA
Hum Pathol; 2008 Jan; 39(1):116-25. PubMed ID: 17949789
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
30. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
31. A novel wnt regulatory axis in endometrioid endometrial cancer.
Zhao Y; Yang Y; Trovik J; Sun K; Zhou L; Jiang P; Lau TS; Hoivik EA; Salvesen HB; Sun H; Wang H
Cancer Res; 2014 Sep; 74(18):5103-17. PubMed ID: 25085246
[TBL] [Abstract][Full Text] [Related]
32. An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1.
Hanigan CL; Van Engeland M; De Bruine AP; Wouters KA; Weijenberg MP; Eshleman JR; Herman JG
Gastroenterology; 2008 Nov; 135(5):1654-1664.e2. PubMed ID: 18834886
[TBL] [Abstract][Full Text] [Related]
33. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
[TBL] [Abstract][Full Text] [Related]
34. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
35. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
36. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
37. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.
Llobet D; Pallares J; Yeramian A; Santacana M; Eritja N; Velasco A; Dolcet X; Matias-Guiu X
J Clin Pathol; 2009 Sep; 62(9):777-85. PubMed ID: 18977806
[TBL] [Abstract][Full Text] [Related]
39. Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer.
Dong W; Tu S; Xie J; Sun P; Wu Y; Wang L
Biochem Biophys Res Commun; 2009 Sep; 387(1):132-8. PubMed ID: 19576178
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
